DEFINING THE PHENOTYPES OF SICKLE CELL DISEASE

被引:14
作者
Ballas, Samir K. [1 ]
机构
[1] Thomas Jefferson Univ, Dept Med, Cardeza Fdn, Jefferson Med Coll, Philadelphia, PA 19107 USA
基金
美国国家卫生研究院;
关键词
Sickle cell disease; Sickle cell anemia; Phenotype; Genotype; Definition; Complications; ACUTE CHEST SYNDROME; LEG ULCERS; ANEMIA; MANIFESTATIONS; SEQUESTRATION; DYSFUNCTION; CHILDREN;
D O I
10.3109/03630269.2011.610477
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The sickle cell gene is pleiotropic in nature. Although it is a single gene mutation, it has multiple phenotypic expressions that constitute the complications of sickle cell disease. The frequency and severity of these complications vary considerably both latitudinally in patients and longitudinally in the same patient over time. Thus, complications that occur in childhood may disappear, persist or get worse with age. Dactylitis and stroke, for example, occur mostly in childhood, whereas leg ulcers and renal failure typically occur in adults. It is essential that the phenotypic manifestations of sickle cell disease be defined accurately so that communication among providers and researchers facilitates the implementation of appropriate and cost-effective diagnostic and therapeutic modalities. The aim of this review is to define the complications that are specific to sickle cell disease based on available evidence in the literature and the experience of hematologists in this field.
引用
收藏
页码:511 / 519
页数:9
相关论文
共 39 条
[11]  
BRAZIER DJ, 1986, T OPHTHAL SOC UK, V105, P100
[12]  
DANA MR, 1993, OPHTHALMOLOGY, V100, P1377
[13]   Etiology of strokes in children with sickle cell anemia [J].
DeBaun, Michael R. ;
Derdeyn, Colin P. ;
McKinstry, Robert C., III .
MENTAL RETARDATION AND DEVELOPMENTAL DISABILITIES RESEARCH REVIEWS, 2006, 12 (03) :192-199
[14]   Finally, a consensus statement on sickle cell disease manifestations: A critical step in improving the medical care and research agenda for individuals with sickle cell disease [J].
DeBaun, Michael R. .
AMERICAN JOURNAL OF HEMATOLOGY, 2010, 85 (01) :1-3
[15]   Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events [J].
Dobson, SR ;
Holden, KR ;
Nietert, PJ ;
Cure, JK ;
Laver, JH ;
Disco, D ;
Abboud, MR .
BLOOD, 2002, 99 (09) :3144-3150
[16]   Pulmonary hypertension as a risk factor for death in patients with sickle cell disease [J].
Gladwin, MT ;
Sachdev, V ;
Jison, ML ;
Shizukuda, Y ;
Plehn, JF ;
Minter, K ;
Brown, B ;
Coles, WA ;
Nichols, JS ;
Ernst, I ;
Hunter, LA ;
Blackwelder, WC ;
Schechter, AN ;
Rodgers, GP ;
Castro, O ;
Ognibene, FP .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (09) :886-895
[17]   CLASSIFICATION AND PATHOGENESIS OF PROLIFERATIVE SICKLE RETINOPATHY [J].
GOLDBERG, MF .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1971, 71 (03) :649-&
[18]   Sickle cell leg ulcers:: a frequently disabling complication and a marker of severity [J].
Halabi-Tawil, M. ;
Lionnet, F. ;
Girot, R. ;
Bachmeyer, C. ;
Levy, P. P. ;
Aractingi, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2008, 158 (02) :339-344
[19]   HEPATIC SEQUESTRATION IN SICKLE-CELL ANEMIA [J].
HATTON, CSR ;
BUNCH, C ;
WEATHERALL, DJ .
BRITISH MEDICAL JOURNAL, 1985, 290 (6470) :744-745
[20]  
Johnson C, 1999, HEMATOL-AM SOC HEMAT, P44